This report
provides comprehensive information on the therapeutic development for Fatigue,
complete with comparative analysis at various stages, therapeutics assessment
by drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for Fatigue
and special features on late-stage and discontinued projects.
Global Markets
Direct's report features investigational drugs from across globe covering over
20 therapy areas and nearly 3,000 indications. The report is built using data
and information sourced from Global Markets Direct's proprietary databases,
Company/University websites, SEC filings, investor presentations and featured
press releases from company/university sites and industry-specific third party
sources, put together by Global Markets Direct's team. Drug profiles/records
featured in the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set of
information. Additionally, processes including live news & deals tracking,
browser based alert-box and clinical trials registries tracking ensure that the
most recent developments are captured on a real time basis.
Browse
Detail Report With TOC @ http://www.hexareports.com/report/fatigue-pipeline-review-h2-2015/details
Scope
- The report provides a snapshot of the global therapeutic landscape of
Fatigue
- The report reviews key pipeline products under drug profile section
which includes, product description, MoA and R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development
for Fatigue and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline
projects
- A review of the Fatigue products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources
- Pipeline products coverage based on various stages of development
ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline
projects
- Coverage of the Fatigue pipeline on the basis of target, MoA, route of
administration and molecule type
- Latest news and deals relating related to pipeline products
Table Of Content
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Fatigue Overview 6
Therapeutics Development 7
Pipeline Products for Fatigue - Overview 7
Pipeline Products for Fatigue - Comparative Analysis 8
Fatigue - Therapeutics under Development by Companies 9
Fatigue - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Fatigue - Products under Development by Companies 13
Fatigue - Companies Involved in Therapeutics Development 14
Biovista Inc. 14
Dimerix Bioscience Pty Ltd 15
Hemispherx Biopharma, Inc. 16
Merz Pharmaceuticals GmbH 17
MultiCell Technologies, Inc. 18
Teva Pharmaceutical Industries Limited 19
Fatigue - Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Combination Products 21
Assessment by Target 22
Assessment by Mechanism of Action 24
Assessment by Route of Administration 26
Assessment by Molecule Type 28
Drug Profiles 30
(lofepramine hydrochloride + phenylalanine) - Drug Profile 30
Request
A Sample copy of This Report @ http://www.hexareports.com/sample/46617
Product Description 30
Mechanism of Action 30
R&D Progress 30
armodafinil - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
DMX-400 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
MRZ-9547 - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
rintatolimod - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecule for Chronic Fatigue Syndrome - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Fatigue - Recent Pipeline Updates 37
Fatigue - Dormant Projects 46
Fatigue - Product Development Milestones 47
Featured News & Press Releases 47
Jun 14, 2010: MultiCell Retains CDSS To Manage MCT-125 Phase IIb Clinical
Trial For PMSF In UK 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49
Browse
Full Report @ http://www.hexareports.com/report/fatigue-pipeline-review-h2-2015/details
About
Us:
Hexa Reports is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact
Information:
Ryan
Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com/
No comments:
Post a Comment